The use of immunobiological monoclonal antibody-based drugs in nephrological practice
Journal Title: Нирки - Year 2018, Vol 7, Issue 3
Abstract
With various diseases of the kidneys, immunobiological monoclonal antibody-based therapy with a different mechanism of action is successfully used. These drugs include: rituximab (interaction with the CD20 receptor and elimination of B cells), eсulizumab (inhibition of C5 complement cleavage), burosumab (blocking fibroblast growth factor 23), adalimumab (anti-tumor necrosis factor α agent), abatacept (blocks co-stimulation of T cells by binding to CD80), fresolimumab (neutralization of transforming growth factor β). These drugs are used for systemic kidney diseases, focal segmental glomerulosclerosis, lupus nephritis, membranous nephropathy, kidney transplantation.
Authors and Affiliations
O. O. Melnyk
Keywords
Related Articles
- EP ID EP369516
- DOI 10.22141/2307-1257.7.3.2018.140208
- Views 103
- Downloads 0
Next Step in Chronic Kidney Disease Therapy
Angiotensin-converting enzyme inhibitors/angiotensin receptor blockers are the basis of renoprotection therapy in chronic kidney disease. Parallel to decrease of glomerular filtration rate, there is an increase in the ac...
Neuroendocrine-Immune Support of Diuretic Effect of Balneotherapy on Truskavets Resort
Objective: to identify concomitant changes in parameters of neuroendocrine-immune complex and colon microbiocenosis, which accompany diuretic effect of balneotherapy on Truskavets resort. Results. The study included 22 m...
Evaluation of Therapeutic and Preventive Potential of Canephron N in Acute Cystitis in Children: Results of Clinical Study
.
Pathogenesis and potential therapy of autosomal dominant polycystic kidney disease
Autosomal dominant polycystic kidney disease (ADPKD) is a hereditary disease characterized by progressive growth of the cyst and an increase in the total volume of the kidneys which leads to kidney failure. The main caus...
Infections of Urinary Tract in Children: 2012 Updating
.